Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1352198

registered interest
date	03/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether people who normally receive a flu vaccination, including people with asthma and lung conditions, will receive a covid-19 booster vaccination in autumn 2021.
tabling member constituency	Leeds Central
tabling member printed	Hilary Benn
uin	41664
answer	answer is ministerial correction date of answer 08/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation’s (JCVI) interim advice is that COVID-19 booster vaccinations should first be offered to the most vulnerable. The JCVI advises a two stage approach, with individuals in stage one offered a booster vaccine and flu vaccine, as soon as possible from September. Individuals in stage two would be offered a booster vaccine as soon as practicable after stage one, with equal emphasis on deployment of the flu vaccine where eligible. The JCVI suggests those aged 16 to 49 years old who are in an influenza or COVID-19 at risk group, including some patients with chronic respiratory disease and asthma are currently included in stage two.</p><p>Final decisions on the timing and scope and cohort eligibility, booster programme will be confirmed once the JCVI has provided their final advice.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 42174 question first answered 08/09/2021 15:14:12 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	413 label Biography information for Hilary Benn

1352544

registered interest
date	03/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the findings of (a) the ONS that chronic lower respiratory disease is the third most common underlying condition with death as a result of covid-19 in quarter 2 of 2021 and (b) of the British Lung Foundation, in its 2012 survey, that 81 per cent of chronic lower respiratory disease is asthma, if he will make it his policy that people with asthma who receive a free annual flu vaccination will be included in any covid-19 booster vaccination programme.
tabling member constituency	North Norfolk
tabling member printed	Duncan Baker
uin	42174
answer	answer is ministerial correction date of answer 08/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation’s (JCVI) interim advice is that COVID-19 booster vaccinations should first be offered to the most vulnerable. The JCVI advises a two stage approach, with individuals in stage one offered a booster vaccine and flu vaccine, as soon as possible from September. Individuals in stage two would be offered a booster vaccine as soon as practicable after stage one, with equal emphasis on deployment of the flu vaccine where eligible. The JCVI suggests those aged 16 to 49 years old who are in an influenza or COVID-19 at risk group, including some patients with chronic respiratory disease and asthma are currently included in stage two.</p><p>Final decisions on the timing and scope and cohort eligibility, booster programme will be confirmed once the JCVI has provided their final advice.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 41664 question first answered 08/09/2021 15:14:11 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4784 label Biography information for Duncan Baker

1350856

registered interest
date	18/08/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	New Businesses: Manufacturing Industries
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps his Department is taking to support start-ups in the manufacturing sector.
tabling member constituency	Wolverhampton South West
tabling member printed	Stuart Anderson
uin	41272
answer	answer is ministerial correction date of answer 09/09/2021 answer text <p>The Government is committed to supporting UK manufacturing businesses, including start-ups and recognises the vital role they play in the UK economy, by driving innovation, exports, job creation and productivity growth.</p><p> </p><p>We are committed to supporting manufacturers to take advantage of innovative technology and we recently announced <a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fnews%2F8-million-government-boost-for-manufacturers-across-england-to-go-digital&amp;data=04%7C01%7Cfilder.onek%40beis.gov.uk%7Caa8df0a9fa1b47253ef508d966631201%7Ccbac700502c143ebb497e6492d1b2dd8%7C0%7C0%7C637653397946777930%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=JbjtVD2pKuArzY4hKwXd7ZbWr5lCJDL85VcFmQvt5pw%3D&amp;reserved=0" target="_blank">£8 million in new government funding for the Made Smarter Adoption programme to help Small and Medium Sized Enterprises (SMEs</a>) increase productivity, competitiveness and drive up efficiency by adopting industrial digital technology, building on the success of our Made Smarter North West Pilot.</p><p> </p><p>The Government’s business support schemes have been put in place to help eligible businesses to get through the pandemic, from all regions and backgrounds. Information on these schemes and other resources is available via the free Business Support Helpline.</p><p> </p><p>The Start Up Loans Company, part of the Government-owned British Business Bank, provides loans and pre- and post-application support to new entrepreneurs, including a year of free business mentoring for successful applicants. Since 2012, over 86,000 Start Up Loans worth over £769 million have been issued to new entrepreneurs. We are also investing £147 million through the Made Smarter Innovation programme to help forward-thinking UK manufacturers create new, green products and processes, slash carbon emissions, drive up productivity and create thousands of highly skilled new jobs across the country.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 09/09/2021 12:39:38 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4742 label Biography information for Stuart Anderson

1350995

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Travel: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that people who have received two covid-19 vaccinations, including Oxford AstraZeneca batch numbers (a) 4120Z001, (b) 4120Z002 and (c) 4120Z003, are able to travel to EU countries.
tabling member constituency	Halifax
tabling member printed	Holly Lynch
uin	41025
answer	answer is ministerial correction date of answer 07/09/2021 answer text <p>The European Union has recently published a list of vaccines it sees as equivalent to those authorised by the European Medicines Agency, for travel purposes which is at the following link:</p><p> </p><p><a href="https://reopen.europa.eu/en" target="_blank">https://reopen.europa.eu/en</a></p><p> </p><p>The list includes all vaccines administered in the United Kingdom, including all batches of AstraZeneca vaccine administered in the UK known commercially as Vaxzevria. This also includes batches 4120Z001, 4120Z002 and 4120Z003. Decisions on which vaccines EU Member States will accept at their borders is for those countries to decide. We are not aware that any have decided not to accept UK vaccines.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/09/2021 15:15:23 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4472 label Biography information for Holly Lynch

1351023

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Travel: Quarantine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, for what reason Government policy makes a distinction between covid-19 vaccines received in the UK and those received overseas when deciding whether a traveller returning from an amber list country needs to quarantine.
tabling member constituency	Plymouth, Sutton and Devonport
tabling member printed	Luke Pollard
uin	41240
answer	answer is ministerial correction date of answer 07/09/2021 answer text <p>The Government is currently undertaking extensive work to consider which regulators and associated vaccines we would recognise. It is important to consider which regulators have similar stringent standards of authorisation as the Medicines Healthcare products Regulatory Agency, which has some of the highest standards of quality, safety and efficacy in the world. This will then feed into discussions regarding quarantine from amber-listed countries.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/09/2021 15:22:34 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4682 label Biography information for Luke Pollard

1351056

registered interest
date	18/08/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Motor Vehicles: Waste Disposal
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, whether his Department has made an assessment of the potential merits of introducing a dedicated scrapping system for diesel and petrol vehicles ahead of the transition towards zero emission vehicles by 2030.
tabling member constituency	Coventry South
tabling member printed	Zarah Sultana
uin	41316
answer	answer is ministerial correction date of answer 09/09/2021 answer text <p>The Government is investing £2.8 billion to support the transition to zero emission vehicles, including to support the uptake of zero and ultra low emission cars, vans, trucks, motorcycles, taxis and buses, as well funding to support charge point infrastructure at homes, workplaces, on residential streets and across the wider roads network, to make charging as easy as refuelling a petrol or diesel car.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 09/09/2021 13:11:15 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4786 label Biography information for Zarah Sultana

1351083

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what criteria his Department will use to determine whether the temporary expansion of eligibility for flu vaccination to people aged over 50 should be made permanent.
tabling member constituency	Halton
tabling member printed	Derek Twigg
uin	40612
answer	answer is ministerial correction date of answer 08/09/2021 answer text <p>Advice from the Joint Committee on Vaccination and Immunisation (JCVI) noted that it was advisable to continue the vaccination of the 50–64-year-old cohort because from the age of 50 years old, individuals are at a greater risk of being hospitalised as a result of COVID-19 and the result of coinfection of COVID-19 and flu is likely to be more severe. However, no decision has been made on whether the eligibility of this cohort will be made permanent.</p><p>The Department will continue to consider the advice of the JCVI in decisions on which flu cohorts are recommended for a flu vaccine in the future. The JCVI use the National Institute for Health and Care Excellence’s methodology and criteria to assess whether a vaccine programme can be considered cost effective or not.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 08/09/2021 15:02:32 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 18931 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	429 label Biography information for Derek Twigg

1351210

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus Certificates
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he taking to help ensure that people who are advised not to have the covid-19 vaccination for clinical reasons are not disadvantaged by the Government's proposals for use of covid-19 certificates.
tabling member constituency	Chipping Barnet
tabling member printed	Theresa Villiers
uin	40730
answer	answer is ministerial correction date of answer 07/09/2021 answer text <p><strong> </strong></p><p>Any venue that adopts COVID-19 status checks as a condition of entry must comply with the relevant legal obligations such as the Equalities Act 2010 when deciding whether or not to accept medical exemptions.</p><p>Senior clinicians are currently drafting clinical guidance which will include and apply to conditions such as multiple sclerosis and other disabilities.</p><p>We will set out our plans shortly for a clinical review of medical exemptions which will enable individuals to show their COVID-19 status using the NHS COVID Pass.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 41252 question first answered 07/09/2021 15:19:53 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1500 label Biography information for Theresa Villiers

1351354

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for people who have (a) multiple sclerosis and (b) other disabilities preventing them from receiving the covid-19 vaccine of the use of vaccine passports which may be mandatory for some activities.
tabling member constituency	Lewisham East
tabling member printed	Janet Daby
uin	41252
answer	answer is ministerial correction date of answer 07/09/2021 answer text <p><strong> </strong></p><p>Any venue that adopts COVID-19 status checks as a condition of entry must comply with the relevant legal obligations such as the Equalities Act 2010 when deciding whether or not to accept medical exemptions.</p><p>Senior clinicians are currently drafting clinical guidance which will include and apply to conditions such as multiple sclerosis and other disabilities.</p><p>We will set out our plans shortly for a clinical review of medical exemptions which will enable individuals to show their COVID-19 status using the NHS COVID Pass.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 40730 question first answered 07/09/2021 15:19:53 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4698 label Biography information for Janet Daby

1351444

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the viability of a covid-19 booster jab for vulnerable groups who were vaccinated earlier in 2021 ahead of winter 2021-22.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Paula Barker
uin	41373
answer	answer is ministerial correction date of answer 08/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation’s (JCVI) interim advice is that COVID-19 booster vaccines should first be offered to the most vulnerable. The JCVI advises a two staged approach, with individuals in stage one offered a COVID-19 booster and flu vaccine, as soon as possible from September. Individuals in stage two would be offered a booster vaccine as soon as practicable after stage one, with equal emphasis on deployment of the flu vaccine where eligible.</p><p>Final decisions on the timing, scope and eligibility will be confirmed once the JCVI has provided their final advice.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 08/09/2021 14:44:41 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4828 label Biography information for Paula Barker